Strategic Analysis of Global Oral Anticoagulants Market Size Projected to Reach USD 34.1 Billion by 2028, Predicts Facts & Factors

NEW YORK, April 5, 2023 /PRNewswire/ -- As per Facts and Factors study, the global oral anticoagulants market size was worth around USD 18 billion in 2021 and is predicted to grow to around USD 34.1 billion by 2028 with a compound annual growth rate (CAGR) of roughly 9.6% between 2022 and 2028.

Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/oral-anticoagulants-market

Oral Anticoagulants Market: Overview

The preferred method of drug delivery in the pharmaceutical industry is oral administration. Oral anticoagulants, often known as blood thinners, are medications that function in conjunction with the body's natural blood-thickening system to prevent and cure unusual blood clots. Patients who have blood clots in the legs (also known as deep vein thrombosis or DVT) or in the lungs (also known as pulmonary embolism or PE), different types of blood clusters in the veins, an irregular heartbeat known as atrial fibrillation that increases the risk of stroke, and mechanical heart valves are all treated with oral anticoagulants. Oral anticoagulants have increased their market share significantly in recent years due to pharmaceutical scientists' improved and full understanding of the biochemical and physicochemical properties and improved patient compliance. Oral anticoagulants have become a popular substitute for traditional pills and capsules. Three novel oral anticoagulant medications have received FDA approval in recent years: Pradaxa (dabigatran), Xarelto (rivaroxaban), and Eliquis (apixaban). All three are "blood thinners," like warfarin, that lower the risk of stroke associated with atrial fibrillation but also induce bleeding.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.fnfresearch.com/sample/oral-anticoagulants-market

Key Insights:

• As per the analysis shared by our research analyst, the global oral anticoagulants market is estimated to grow annually at a CAGR of around 9.6% over the forecast period (2022-2028).
• In terms of revenue, the global oral anticoagulants market size was valued at around USD 18 billion in 2021 and is projected to reach USD 34.1 billion, by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
• Based on the product, the warfarin segment held the largest market share in 2021.
• Based on end users, the hospital pharmacies segment accounted for the major market share in 2021 and is expected to show its dominance during the forecast period.
• Based on region, North America is projected to dominate the market during the forecast period.

Facts and Factors published the latest report titled "Oral Anticoagulants Market Size, Share, Growth Analysis Report By Product (Warfarin and Novel Oral Anticoagulant), By Disease Indication (Atrial Fibrillation (AF)/ Stroke Prevention and Deep Vein Thrombosis/ Pulmonary Embolism), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" into their research database.

Industry Dynamics:

Global Oral Anticoagulants Market: Growth Drivers

• The increasing geriatric population coupled with the growing prevalence of chronic disease drives the market.

The increasing geriatric population coupled with the growing prevalence of chronic disease is expected to propel the global oral anticoagulants market growth during the forecast period. The market for oral anticoagulants has seen widespread drug use, particularly among elderly patients at risk for heart attacks. With increasing age, atrial fibrillation (AF) becomes a more common cause of avoidable, incapacitating stroke. Worldwide public health concerns with AF-related stroke are developing as people live longer. The majority of AF patients are elderly (average age, 75), and getting older is a reliable, independent risk factor for an AF-related stroke. Anticoagulation with warfarin is quite efficient at preventing strokes in AF patients, but it is rarely used, especially in the elderly. Oral anticoagulants increase the risk of hemorrhage in senior people, however for the majority of these patients, the benefit of ischemic stroke reduction outweighs the risk of hemorrhage. 

Related report on LinkedIn:

Global Fire Doors Market: https://www.linkedin.com/pulse/latest-global-fire-doors-market-sizeshare-worth-usd-166-ram-rupnur

Global Metalworking Fluids Market: https://www.linkedin.com/pulse/350-cagr-global-metalworking-fluids-market-size-share-surpass

Global Uncoated Paint Protection Film Market: https://www.linkedin.com/pulse/latest-global-uncoated-paint-protection-film-market-sizeshare

Global IoT Devices Market: https://www.linkedin.com/pulse/latest-global-iot-devices-market-sizeshare-worth-usd-272442-kumar

Global Oral Anticoagulants Market: Restraints

• The possible side effect associated with oral anticoagulants hamper the market growth.

The development of the global oral anticoagulants market during the forecast period may be hampered by potential negative effects from anticoagulants or blood thinners. Excessive bleeding is the main negative side effect of taking these medications. A common example is an anticoagulant warfarin, which also carries an increased risk of other side effects such as skin necrosis, blue or purple toes, congenital impairments, and miscarriages. Anticoagulants are typically not recommended for persons with AFib, high blood pressure, or other conditions to prevent problems.

Directly Purchase a Copy of the Report @ https://www.fnfresearch.com/buynow/su/oral-anticoagulants-market

Global Oral Anticoagulants Market: Segmentation

• The global oral anticoagulants market is segmented based on product, disease indication, distribution channel, and region.

Based on the product, the global market is bifurcated into warfarin and novel oral anticoagulant. The warfarin segment held the largest market share in 2021 and is expected to show its dominance during the forecast period. Warfarin is an oral anticoagulant that is commonly used to treat and prevent blood clots. Warfarin has multiple FDA-approved and off-label clinical uses such as Prophylaxis and treatment of venous thrombosis and arising pulmonary embolisms, Prophylaxis and treatment of thromboembolic complications from atrial fibrillation or cardiac valve replacement, reduction in the risk of death, recurrent myocardial infarction, thromboembolic events (e.g., stroke, systemic embolization) after myocardial infarction, and secondary prevention of recurrent stroke and transient ischemic attacks. On the other hand, novel oral anticoagulants are expected to grow at the highest CAGR during the forecast period. The novel oral anticoagulants include dabigatran etexilate, rivaroxaban, edoxaban and apixaban. These anticoagulants have major pharmacologic preferences over vitamin K antagonists, including counterbalance of functional activity, and unsurprising pharmacokinetics, disposing of the prerequisite for general coagulation observing. Thus, driving the segment growth.

Based on distribution channels, the global market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment accounted for the largest market share in 2021 and is expected to dominate over the forecast period. Hospital pharmacies offer several advantages, including better access to medications. A significant share of CVD patients visits hospital outpatient departments (OPDs) to receive treatment and medication prescriptions since these departments have more sophisticated infrastructure and medical staff. Anticoagulant sales across in-house pharmacies will increase at a large rate as more patients choose to receive their treatments at hospitals to receive high-quality care.

Get More Insight before Buying@: https://www.fnfresearch.com/inquiry/oral-anticoagulants-market

List of Key Players in Oral Anticoagulants Market:

• Johnson & Johnson
• Bayer AG
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company
• Abbott Laboratories
• Aspen Holdings
• Sanofi
• Pfizer Inc
• Alexion Pharmaceuticals Inc.
• Leo Pharma AS
• Dr. Reddy's Laboratories

Key questions answered in this report:

• What are the growth rate forecast and market size for ORAL ANTICOAGULANTS Market?
• What are the key driving factors propelling the ORAL ANTICOAGULANTS Market forward?
• What are the most important companies in the ORAL ANTICOAGULANTS Market Industry?
• What segments does the ORAL ANTICOAGULANTS Market cover?
• How can I receive a free copy of the ORAL ANTICOAGULANTS Market sample report and company profiles?

Report Scope:

 Free Brochure: https://www.fnfresearch.com/ask-to-analyst/oral-anticoagulants-market

Regional Dominance:

• North America is expected to dominate the market during the forecast period.

North America is expected to dominate the global oral anticoagulants market during the forecast period. Due to the strong demand for cutting-edge products and the rising prevalence of cardiovascular diseases, North America is predicted to hold a significant market share in the global market for oral anticoagulants. For instance, in 2021, the American Heart Association estimates that around 2,300 Americans would die daily from cardiovascular disorders, or one every 38 seconds. Moreover, according to the Center for Disease Control and Prevention in February 2022, about 659,000 Americans die of heart disease annually. This represents almost 25% of all United States deaths. Thus increase in cardiovascular diseases the demand for anticoagulants increases in the region thereby boosting the market.

Global Oral Anticoagulants Market is segmented as follows:

Oral Anticoagulants Market: By Product Outlook (2023-2028)

• Warfarin
• Novel Oral Anticoagulant

Oral Anticoagulants Market: By Disease Indication Outlook (2023-2028)

• Atrial Fibrillation (AF)/ Stroke Prevention
• Deep Vein Thrombosis/ Pulmonary Embolism

Oral Anticoagulants Market: By Distribution Channel Outlook (2023-2028)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Oral Anticoagulants Market: By Region Outlook (2023-2028)

North America

• The U.S.
• Canada

Europe

• France
• The UK
• Spain
• Germany
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa

Press Release: https://www.fnfresearch.com/news/global-oral-anticoagulants-market

Browse Other Related Research Reports from Facts and Factors

• Rheumatoid Arthritis Drugs Market: According to the report published by Facts and Factors, the global rheumatoid arthritis drugs market size was worth around USD 60.1 billion in 2021 and is predicted to grow to around USD 70.1 billion by 2030 with a compound annual growth rate (CAGR) of roughly 1.75% between 2022 and 2030.
• Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: According to the report published by Facts Factors, the global chimeric antigen receptor (CAR) T-Cell therapy market size was worth around USD 1.69 billion in 2021 and is predicted to grow to around USD 6 billion by 2030 with a compound annual growth rate (CAGR) of roughly 13.49% between 2022 and 2030.
• Spirulina Market: According to the report published by Facts Factors, the global spirulina market size was worth around USD 410.2 million in 2021 and is predicted to grow to around USD 989.6 million by 2028 with a compound annual growth rate (CAGR) of roughly 11.1% between 2022 and 2028.
• Gene Synthesis Market: According to Facts and Factors, the global gene synthesis market size was worth around USD 1,528.10 million in 2021 and is estimated to grow to about USD 4,021.41 million by 2028, with a compound annual growth rate (CAGR) of approximately 17.50% over the forecast period.
• Biohacking Market: The latest report published by Facts & Factors titled global biohacking market has a global perspective on the latter coupled with the market size, volume, drivers, and restraints to name a few. We estimate that the biohacking market will hold a value of USD 14.65 Billion in the year 2020 with a CAGR growth of 21.1% which was previously subjected at USD 65.4 Billion in the year 2026.

Browse through Facts and Factors's coverage of the Global Pharmaceuticals Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Facts and Factors is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Facts and Factors
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158
Email: sales@fnfresearch.com
Website: https://www.fnfresearch.com/

Logo: https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg